Ciprofloxacin resistance in community and hospital-acquired urinary tract infections: a systematic review and meta-analysis from African population
Abstract
Background: Since the introduction of fluorinated derivatives (fluoroquinolones) in the 1980s, these agents, especially ciprofloxacin, have become standard treatment for various bacterial infections, including urinary tract infections (UTIs). Frequently, in developing countries UTIs are treated empirically due to limited capacity of the culture and sensitivity testing in most health facilities. Despite the high usage, there is a scarcity of data regarding ciprofloxacin resistance/susceptibility pattern among uropathogens isolated in Africa. This study aimed to conduct a systematic review to ascertain the rate of ciprofloxacin resistance among uropathogens in Africa and identify the most common fluoroquinolone-resistant uropathogens in the region.
Methods: We used the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines to search the PubMed, Embase and Scopus databases, as well as grey literature search, for articles reporting on the antibiotic susceptibility of uropathogens in African countries between January 2010 and December 2023.
Results: A total of 2940 articles were screened resulting to 44 relevant studies that were included, from three regions of Africa; East, West and North Africa. Majority of the studies were from East Africa (35/44; 79.5%) whilst North Africa contributed few numbers of studies (3/44; 6.8%). The overall rate of uropathogens resistant to ciprofloxacin in Africa was 34% (95%, CI = 0.27-0.40) which was from isolates…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.